Meaningful amelioration of quality of life in paediatric AD patients on dupilumab TrialPhase 3, LIBERTY AD PEDS ConferenceAAD VMX 2021 7 June, 2021 13:00
IL-4/IL-13 blocker dupilumab effective in children with severe AD Presented ByProf. Amy S. Paller, Northwestern University Feinberg School of Medicine, USA TrialPhase 3, LIBERTY AD PEDS ConferenceAAD 2020 6 August, 2020 07:04